Poxel Announces Its 2016 Financial Calendar

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announces its schedule for the publication of financial information for 2016.